New Zealand (NZX) Pharma Industry Analysis
UpdatedOct 30, 2023
DataAggregated Company Financials
Companies5
- 7D-0.6%
- 3M-9.9%
- 1Y-14.3%
- YTD-17.8%
Over the last 7 days, the Pharma industry has remained flat, although notably Rua Bioscience gained 11%. Unfortunately though, the industry is down 14% over the past 12 months. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the New Zealand Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 30 Oct 2023 | NZ$463.9m | NZ$167.6m | NZ$3.3m | 33.5x | 138.7x | 2.8x |
| Wed, 27 Sep 2023 | NZ$463.0m | NZ$167.6m | NZ$3.3m | 32.9x | 138.4x | 2.8x |
| Fri, 25 Aug 2023 | NZ$499.2m | NZ$167.6m | -NZ$4,073,109.00 | 35.4x | -122.6x | 3x |
| Sun, 23 Jul 2023 | NZ$519.7m | NZ$167.6m | -NZ$4,073,109.00 | 36.4x | -127.6x | 3.1x |
| Tue, 20 Jun 2023 | NZ$514.4m | NZ$167.6m | -NZ$4,073,109.00 | 34.4x | -126.3x | 3.1x |
| Thu, 18 May 2023 | NZ$465.4m | NZ$150.7m | NZ$1.1m | 20.9x | 430.1x | 3.1x |
| Sat, 15 Apr 2023 | NZ$470.9m | NZ$150.7m | NZ$1.1m | 20.9x | 435.2x | 3.1x |
| Mon, 13 Mar 2023 | NZ$502.4m | NZ$150.7m | NZ$1.1m | 22.2x | 459.4x | 3.3x |
| Wed, 08 Feb 2023 | NZ$516.7m | NZ$153.3m | NZ$1.2m | 23.4x | 427.4x | 3.4x |
| Fri, 06 Jan 2023 | NZ$515.1m | NZ$153.3m | NZ$1.2m | 23x | 426x | 3.4x |
| Sun, 04 Dec 2022 | NZ$514.6m | NZ$153.3m | NZ$1.2m | 22.7x | 425.7x | 3.4x |
| Tue, 01 Nov 2022 | NZ$516.3m | NZ$143.0m | NZ$3.9m | 19.6x | 132.7x | 3.6x |
| Thu, 29 Sep 2022 | NZ$492.5m | NZ$143.0m | NZ$3.9m | 17.9x | 126.6x | 3.4x |
| Sat, 27 Aug 2022 | NZ$506.1m | NZ$142.3m | NZ$8.0m | 18x | 63.4x | 3.6x |
| Mon, 25 Jul 2022 | NZ$578.3m | NZ$141.0m | NZ$9.7m | 21.1x | 59.5x | 4.1x |
| Wed, 22 Jun 2022 | NZ$534.7m | NZ$141.0m | NZ$9.7m | 19.8x | 55x | 3.8x |
| Fri, 20 May 2022 | NZ$476.4m | NZ$130.2m | NZ$920.3k | 30.5x | 517.7x | 3.7x |
| Sun, 17 Apr 2022 | NZ$554.5m | NZ$130.2m | NZ$920.3k | 35.9x | 602.5x | 4.3x |
| Tue, 15 Mar 2022 | NZ$554.6m | NZ$130.2m | NZ$2.2m | 36.1x | 254.7x | 4.3x |
| Thu, 10 Feb 2022 | NZ$621.8m | NZ$129.0m | -NZ$95,598.00 | n/a | -6504.6x | 4.8x |
| Sat, 08 Jan 2022 | NZ$662.6m | NZ$129.0m | -NZ$95,598.00 | n/a | -6930.9x | 5.1x |
| Mon, 06 Dec 2021 | NZ$664.2m | NZ$129.0m | -NZ$95,598.00 | 44.3x | -6947.7x | 5.1x |
| Wed, 03 Nov 2021 | NZ$672.5m | NZ$124.1m | -NZ$281,598.00 | n/a | -2388.2x | 5.4x |
| Fri, 01 Oct 2021 | NZ$627.7m | NZ$124.1m | -NZ$281,598.00 | 102.3x | -2229.2x | 5.1x |
| Sun, 29 Aug 2021 | NZ$647.9m | NZ$124.7m | -NZ$281,598.00 | 104.2x | -2300.7x | 5.2x |
| Mon, 05 Jul 2021 | NZ$663.2m | NZ$124.7m | -NZ$281,598.00 | 86.9x | -2355.2x | 5.3x |
| Thu, 08 Apr 2021 | NZ$714.5m | NZ$124.7m | NZ$307.1k | 98.9x | 2326.2x | 5.7x |
| Sun, 10 Jan 2021 | NZ$832.9m | NZ$122.2m | -NZ$823,103.00 | 91.2x | -1011.9x | 6.8x |
Price to Earnings Ratio
-480.5x
Current Industry PE
- Investors are optimistic on the New Zealander Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 139x which is higher than its 3-year average PE of -726x.
- The 3-year average PS ratio of 4.4x is higher than the industry's current PS ratio of 2.8x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 12% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the New Zealand Healthcare industry?
| NZ Market | -2.02% | |
| Healthcare | -0.68% | |
| Pharma | -0.62% | |
| Pharma | -0.62% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CBD Cannasouth | NZ$0.19 | 4.9% +NZ$2.9m | n/a | n/a | |
| RUA Rua Bioscience | NZ$0.12 | 11.4% +NZ$1.9m | -51.2% | PS27.7x |